Business
Biomira completes U.S. $16.07 million financing
Biomira completes U.S. $16.07 million financing.
About this update from Skrr Exploration, Inc.
[{"type":"text","content":"\n\n\n\n\nEDMONTON, Feb. 8 /CNW/ - Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) today\nannounced the completion at the end of January of its financing totaling U.S.\n$16,070,000, with Rodman & Renshaw LLC of New York acting as exclusive\nplacement agent. The financing announced on January 27, 2006 was fully\nsubscribed.\n\nAbout Biomira\n\nBiomira is a biotechnology company specializing in the development of\ninnovative therapeutic approaches to cancer management. Biomira's commitment\nto the treatment of cancer currently focuses on the development of synthetic\nvaccines and novel strategies for cancer immunotherapy.\n\n\n\n","length":686,"tagName":"div"}]